Los Angeles Bioscience Ecosystem Summit '23 announces Keynote Speaker, Daren Tang, Director General of the United Nations WIPO. Los Angeles Area Bioscience Academic institutions, researchers, industry, and investors to converge at UCLA Meyer and Renee Luskin Conference Center on May 25, 2023.
LOS ANGELES, April 3, 2023 /PRNewswire-PRWeb/ -- UCLA Technology Development Group (UCLA TDG) presents the Los Angeles Bioscience Ecosystem Summit '23 (LABEST, pronounced L-A Best). This event is the premier showcase for bioscience innovation in Southern California. With national and international presenters and attendees and a true collaboration with colleagues from across LA county, LABEST presents promising academic research, entrepreneurial faculty investigators, and local startup companies. The goal is to highlight the vibrant startup ecosystem and promote awareness of the growing life science entrepreneurial ecosystem in Los Angeles to facilitate partnerships between academia, the biopharma industry, entrepreneurs and investors.
"This year's LABEST conference will feature a welcome by Chancellor Block followed by a fireside chat with UC Board of Regents Chair Richard Leib and Regent Lark Park. The Chancellor and the Regents will discuss the significance of innovation and entrepreneurship at the University and how it propels its mission of service. We are also honored to host the Director General of the World Intellectual Property Organization (WIPO), Mr. Daren Tang," said Amir Naiberg, Associate Vice Chancellor, CEO & President, UCLA TDG (Technology Development Group).
UCLA TDG is excited to fill the UCLA Meyer and Renee Luskin Conference Center once again for the 2023 event, which will be held on May 25, 2023. Throughout the summit, faculty members present the latest scientific breakthroughs, which may lead to the critical therapies of tomorrow. Leading bioscience translational research programs and startups will be showcased where Southern California Institutions have significant expertise, pioneering research and resource commitments to develop innovative patient therapies.
LABEST is led by Mark Wisniewski, Senior Director, BioPharmaceuticals, UCLA TDG. He adds, "We are on our 5th year of the LABEST conference at UCLA. We started with the idea to advance LA as a bioscience ecosystem by showcasing the best research across the LA academic institutions. In 2023, I can say that this has greatly exceeded expectations as this event has attracted the participation of stakeholders from research programs, incubators, biomanufacturing facilities, investment funds, startups and biopharma. We are in a growth stage of the ecosystem and it's exciting for Los Angeles."
LABEST INFORMATION #LABEST2023 @UCLATDG
DATE: May 25, 2023
TIME: 8:30am – 7:00pm PT
LABEST OFFICIAL WEBPAGE: Link
LINK TO 2023 PROMOTIONAL VIDEO: Link
REGISTRATION: Link
WHERE: UCLA Meyer and Renee Luskin Conference Center
AGENDA: Link
KEYNOTE SPEAKER
- Daren Tang - United Nations World Intellectual Property Organization Director General (UN WIPO)
CONFERENCE HIGHLIGHTS
- In-person conference taking place at the UCLA Meyer and Renee Luskin Conference Center
- 2 Top notch panels and fireside chat with UC Regents
- 12 Interactive Showcases
- Los Angeles Startup Ecosystem Showcase, Co-Hosted by the Larta Institute and the Lundquist Institute
LABEST SHORT TALK/PANEL DESCRIPTIONS
- Panel - LA Hospital Leaders Innovating For Future Success: Moderator Judy Fortin, Executive Director of Communications UCLA Health & David Geffen School of Medicine. A panel discussion with Hospital CEOs from our long-standing LABEST partners in the Los Angeles area, covering challenges, accomplishments, and what the future has in store for Hospitals.
- Panel - Meet The Leaders in the Business of Life Sciences: Moderator Arie Belldegrun, MD FACS, Chairman Bellco Capital. A panel discussion with CEOs of Life Sciences companies discussing recent discoveries, new diseases and drug discoveries in the pipeline.
- Showcase - UCLA Metabolism: Led by Orian Shirihai, MD, PhD, Metabolism Theme Chair. Topics to include Liver disease, Myopathies, Cancer & Immuno-Metabolism, and Obesity & Diabetes.
- Showcase - UCLA Jonsson Comprehensive Cancer Center: Led by Edward B. Garon, MD, MS, Thoracic Medical Oncology.
UCLA Technology Development Group (TDG) serves as a campus-wide gateway to UCLA innovation, research and entrepreneurship. Our mission is to: - Promote UCLA innovation, research, teaching and entrepreneurship to benefit society -Create economic value to support UCLA's scholarly and educational missions and the State of California -Lead UCLA's research community to bring innovation to market
TDG Website
Thank you to our Innovator Sponsors:
Amgen
Kite, A Gilead Company
Media Contact
Valerie Allen, Valerie Allen Public Relations, 1 3103827800, [email protected]
SOURCE UCLA Technology Development Group (UCLA TDG)
Share this article